The Emerging Biotech Leader
The Emerging Biotech Leader
Podcast Description
Biotech—it's complicated.
A successful product launch requires grit, determination, and clear direction.
But let’s be real, the path to launch isn’t a straight one.
There are curves, hard turns, and dead ends.
Here’s the good news, you don’t have to navigate the complexities alone.
Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
Podcast Insights
Content Themes
The podcast explores critical topics in the biotech field, including leadership dynamics, strategic board engagement, risk management, and the evolving role of CMOs. Episodes such as 'The Road Ahead: Biotech in 2025' and 'Patients as Partners: A Winning Strategy for Drug Development' illustrate the multi-faceted challenges and opportunities present in clinical development and product launch.
Biotech—it’s complicated.
A successful product launch requires grit, determination, and clear direction.
But let’s be real, the path to launch isn’t a straight one.
There are curves, hard turns, and dead ends.
Here’s the good news, you don’t have to navigate the complexities alone.
Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
Dr. Carrie Brownstein shares lessons from her own path from large pharma to biotech and how different kinds of experience shape what a CMO can offer at different points in a company’s growth.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.